Page last updated: 2024-09-05

lapatinib and bms201038

lapatinib has been researched along with bms201038 in 1 studies

Compound Research Comparison

Studies
(lapatinib)
Trials
(lapatinib)
Recent Studies (post-2010)
(lapatinib)
Studies
(bms201038)
Trials
(bms201038)
Recent Studies (post-2010) (bms201038)
1,9193051,44212813106

Protein Interaction Comparison

ProteinTaxonomylapatinib (IC50)bms201038 (IC50)
Delta-type opioid receptorMus musculus (house mouse)0.0008
Microsomal triglyceride transfer protein large subunitHomo sapiens (human)0.0056

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Combrinck, JM; de Sousa, ACC; Egan, TJ; Maepa, K1

Other Studies

1 other study(ies) available for lapatinib and bms201038

ArticleYear
Lapatinib, Nilotinib and Lomitapide Inhibit Haemozoin Formation in Malaria Parasites.
    Molecules (Basel, Switzerland), 2020, Mar-29, Volume: 25, Issue:7

    Topics: Antimalarials; Benzimidazoles; Binding Sites; Chloroquine; Drug Repositioning; Drug Resistance; Erythrocytes; Hemeproteins; High-Throughput Screening Assays; Humans; Inhibitory Concentration 50; Lapatinib; Molecular Docking Simulation; Plasmodium falciparum; Pyrimethamine; Pyrimidines; Thermodynamics

2020